Hi 2013, thanks for explaining what you think the facts are and what you think the statistics mean. Without wishing to be rude, I have to say that nfortunately, some of your statements are incorrect and in others you have completely missed the point. Given the seriousness of what you are trying to do, I feel I should clarify this. Please do not be offended, but others reading it need to have the correct facts.
.1)You miss the point made in the first article referenced. the BCRIG006 Trial from 2006 compared two effective drug-regimes:
AC-T ie doxorubicin and cyclophosphamide followed by docetaxel (this included Doxorubicin which is very effective against cancer but caused a significant rate of permanent heart damage).
TCH, ie herceptin plus Carboplatin and Docetaxel, also very effective but caused less heart damage, and what heart damage it did cause was reversible once you stopped taking herceptin.
The point missed was that the point of the trial was to show that at last women could get effective treatment to prevent HER2+BC recurrence without suffering permanent and irreversible heart damage. This is a much worse side effect than Herceptin's well-known flu-like symptoms which reverse when you stop taking the drug. (BTW neuropathy is not caused by Herceptin it is caused by the two chemo drugs)
2) About Herceptin and Recurrences: My oncologist told me that with no treatment but surgery for my node-neg, Grade 3, 2.2cm HER2posbreast cancer, I had a 45% chance of a recurrence within 5yrs that would be likely to kill me.
With the TCH treatment with herceptin, I had only an 8%chance of a recurrence within 5yrs.
With AC-T chemo I had a slightly lower chance of a recurrence and would avoid the chance of getting the flu-like symptoms that many of us get from herceptin..Instead I would have a much higher chance of permanent congestive heart failure from the Doxorubicin .And a good chance that I would still die younger than I should, but from heart disease, not from breast cancer.
3)The latest Herceptin research trials using paclitaxel and herceptin on unde r3cm node-negative HER2+ cancer showed a 3-year rate of survival free from invasive disease of 98.7%. ie a 3yr recurrence rate of about 2%. This means that the success rate of treatment with herceptin is getting better and better. http://www.nejm.org/doi/full/10.1056/NEJMoa1406281
4)Your 2nd reference is from healthynet.com which is a very questionable, non-scientific, unreliable, and very-anti-traditional-medicine source which does not actually quote any peer-reviewed scientific research,or any evidence-based information, and it simply presents its own bias, not facts.
5) You say "I am BC free, meaning my BC can no longer be detected after surgery. In my case the risks and benefits is not so clear. I accepted there is no certainty in the reoccurrence of my BC or the benefit of the treatment to stop the reoccurrence. However, with me my joints pain and ageing (osteoporosis) is certain"
Sadly, when HER2+ BC is no longer detectable, all you/we know for sure is that you probably do not have any tumors over 1cm in your body. It does not mean that you are BC free, just that it is no longer detectable. The key problem is that you almost certainly still have BC cancer stem cells in your lymph and blood immediately after surgery, which are indetectable but which are able to generate local recurrence or spread to bone, liver, lungs or brain etc to grow into new metastases. They may even have already set up tiny metastases that are too small to show up on scans. The risk of this is highest immediately after surgery, decreasing to very minimal risk after 5 yrs. Research shows that Herceptin does a very good job of getting rid of these tiny metastases so they are gone before you even know they were there. Research also shows that Herceptin actively works on Cancer Stem Cells.Your immune system works on them too. And their presence doesn't mean they are certain to grow into a recurrence, just that they could. Herceptin is invaluable to prevent possible or probably recurrence.
In this way it cuts my chance of recurrence down from 45% to 8% without permanently damaging my heart. To me that is a very sensible choice.But the circulating Cancer stem cells are BC cells, and they and the possibility they will produce metastases in the future are a part of what we have to learn to live with. Herceptin and its related targetted therapies are important to help protect us and extend our lives, with minimal serious side effects, and research shows this to be so.
Have you asked your oncologist why he put you onto TCH treatmentL Have you said that you would prefer to be on the AC-T treatment or untreated? If you are convinced that herceptin is so bad for you, instead of trying to stop others having access to this drug, why not discuss this in depth with your oncologist explaining that you do not want any more of it and want to stop taking it? Australia's PBS is paying $50,000 a year for you (and the same for each of us) to have this drug for a year, and if you think it is a bad choice, why continue? It is your choice, and your right to change, even though I would strongly advise against it.